Assignee profile

Revolution Medicines

Coverage of patents, compounds and activity records linked to this assignee.

2 patents132 compounds278 activity records
Summary
AssigneeRevolution Medicines
Filing years2023-2025
Patents2
Compounds132
Activity records278
Patent families2
Targets3
Assay familiesbinding, biochemical, viability
Activity metricsEC50, IC50, Kd, inhibition
Overview

Target distribution and active-compound trend

Target distribution

278 activity records

3 targets

Active compounds by publication year

Distinct compounds linked to assignee patent publications

06412820232025
Activity compounds and values

Activity records

278 records
Structure
Control
Value
ConcentrationTime
Record IDCompoundAssayDetails
2D structure for PGDB_C008266
% Inhibition-=96.62%--PPIA--JP2023161027APGDB_A007310PGDB_C008266PGDB_AS001219View
2D structure for PGDB_C008207
% Inhibition-=93.35%--PPIA--JP2023161027APGDB_A007603PGDB_C008207PGDB_AS001219View
2D structure for PGDB_C008238
IC50-<2uM-—PPIA--JP2023161027APGDB_A008051PGDB_C008238PGDB_AS000607View
2D structure for PGDB_C008272
IC50-<2uM-—PPIA--JP2023161027APGDB_A008356PGDB_C008272PGDB_AS000607View
2D structure for PGDB_C008272
% Inhibition-=96.9%--PPIA--JP2023161027APGDB_A008529PGDB_C008272PGDB_AS001219View
2D structure for PGDB_C008244
IC50-<2uM-—PPIA--JP2023161027APGDB_A008595PGDB_C008244PGDB_AS000607View
2D structure for PGDB_C008231
% Inhibition-=79.54%--PPIA--JP2023161027APGDB_A008606PGDB_C008231PGDB_AS001219View
2D structure for PGDB_C008237
IC50-<2uM-—PPIA--JP2023161027APGDB_A008813PGDB_C008237PGDB_AS000607View
2D structure for PGDB_C008176
Kd-=66nM-—FKBP1A--JP2023161027APGDB_A008980PGDB_C008176PGDB_AS000010View
2D structure for PGDB_C008171
Kd-=0.34nM-—FKBP1A--JP2023161027APGDB_A009244PGDB_C008171PGDB_AS001324View
2D structure for PGDB_C008283
% Inhibition-=95.72%--PPIA--JP2023161027APGDB_A009763PGDB_C008283PGDB_AS001219View
2D structure for PGDB_C008245
IC50-<2uM-—PPIA--JP2023161027APGDB_A009872PGDB_C008245PGDB_AS000607View
2D structure for PGDB_C008247
IC50-<2uM-—PPIA--JP2023161027APGDB_A010109PGDB_C008247PGDB_AS000607View
2D structure for PGDB_C008286
IC50-<2uM-—PPIA--JP2023161027APGDB_A010218PGDB_C008286PGDB_AS000607View
2D structure for PGDB_C008177
Kd-=0.3nM-—FKBP1A--JP2023161027APGDB_A010244PGDB_C008177PGDB_AS001324View
2D structure for PGDB_C008225
% Inhibition-=72.88%--PPIA--JP2023161027APGDB_A010407PGDB_C008225PGDB_AS001219View
2D structure for PGDB_C008223
IC50-<2uM-—PPIA--JP2023161027APGDB_A010605PGDB_C008223PGDB_AS000607View
2D structure for PGDB_C008245
% Inhibition-=99.23%--PPIA--JP2023161027APGDB_A010922PGDB_C008245PGDB_AS001219View
2D structure for PGDB_C008281
% Inhibition-=95.3%--PPIA--JP2023161027APGDB_A011823PGDB_C008281PGDB_AS001219View
2D structure for PGDB_C008226
% Inhibition-=95.36%--PPIA--JP2023161027APGDB_A011913PGDB_C008226PGDB_AS001219View
Page 1 of 14 · 278 records